CEXAX Performance — Camelot Excalibur Small Cap Income Fund, Class A
Data updated: 2020-08-28
In the 12 months to Jun 2020 the fund took in a net $4.5M, and assets reached $6.41M.
CEXAX Growth of $100
What $100 invested in Camelot Excalibur Small Cap Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | CEXAX | Category average |
|---|---|---|
| Since data start (Jan 2020 – Jun 2020) | $96 | $92 |
CEXAX Annual Returns
Calendar-year total returns of Camelot Excalibur Small Cap Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2020 (Jan–Jun) | −4.35% |
CEXAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | −0.1% | −2.1% | −21.4% | +17.7% | +2.9% | +2.8% | — | — | — | — | — | — |
CEXAX Risk
Risk measures from monthly returns over Jan 2020 – Jun 2020.
- Best month: +17.68% (Apr 2020)
- Worst month: −21.39% (Mar 2020)
CEXAX Fund Flows
Monthly money in and out of Camelot Excalibur Small Cap Income Fund, from SEC Form N-PORT.
- 12-month net flow: $4.5M
- 12-month gross sales (incl. reinvestments): $941K
- Sales ÷ redemptions: -0.26×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2020 | $86K | −$269K | $355K |
| May 2020 | $111K | −$436K | $546K |
| Apr 2020 | $35K | −$456K | $492K |
| Mar 2020 | $56K | −$500K | $556K |
| Feb 2020 | $127K | −$224K | $351K |
| Jan 2020 | $526K | −$1.7M | $2.2M |
CEXAX Assets Under Management
Net assets of Camelot Excalibur Small Cap Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2020-06-30 | $6.41M |
| 2020-03-31 | $6.06M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.